Home ETF List About

Portfolio Holdings Detail for ISIN IE000G2LIHG9
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSAUA(EUR) ETF Plus

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Royal Bank Of Canada from $435.00 to $500.00 in a report issued on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other reports. The Goldman Sachs Group boosted their price […] - 2025-09-22 02:32:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $520.00 Price Target at Bank of America
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective raised by Bank of America from $453.00 to $520.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on ALNY. Oppenheimer upgraded shares […] - 2025-09-18 04:26:54
The Goldman Sachs Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by The Goldman Sachs Group from $504.00 to $566.00 in a report published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Chardan Capital lifted […] - 2025-09-17 03:14:44
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $421.28
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and twenty-three have issued a buy recommendation on the company. The average 1 year target price […] - 2025-09-15 02:47:58
Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre - 2025-09-10 00:33:28
Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op - 2025-09-09 00:30:30
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Dennis A. Ausiello Sells 31,448 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Dennis A. Ausiello sold 31,448 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $436.58, for a total value of $13,729,567.84. Following the completion of the sale, the director directly owned 911 shares in […] - 2025-08-18 05:14:55
LPL Financial LLC Buys 2,107 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
LPL Financial LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,679 shares of the biopharmaceutical company’s stock after acquiring an additional 2,107 shares during the period. LPL Financial LLC’s holdings […] - 2025-08-13 05:04:56
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Cetera Investment Advisers Has $2.17 Million Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Cetera Investment Advisers raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 68.1% during the first quarter, Holdings Channel reports. The firm owned 8,017 shares of the biopharmaceutical company’s stock after purchasing an additional 3,247 shares during the period. Cetera Investment Advisers’ holdings in Alnylam Pharmaceuticals were worth $2,165,000 at the end […] - 2025-08-08 04:44:59
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Oppenheimer
Oppenheimer upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage currently has $490.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. Barclays lifted their price […] - 2025-08-07 02:54:47
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by Wolfe Research to Peer Perform Rating
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating in a research report issued on Monday, Marketbeat reports. A number of other brokerages have also recently issued reports on ALNY. Canaccord Genuity Group lifted their price target on shares […] - 2025-08-06 03:02:54
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $400.00 at Chardan Capital
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Chardan Capital from $325.00 to $400.00 in a research report report published on Friday,Benzinga reports. Chardan Capital currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Needham & Company LLC raised their […] - 2025-08-04 02:48:47
Needham & Company LLC Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $478.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target hoisted by Needham & Company LLC from $377.00 to $478.00 in a research report report published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on the […] - 2025-08-03 05:28:56
Noteworthy ETF Outflows: XBI, MRNA, ALNY, EXEL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $225.3 million dollar outflow -- that's a 4.6% decrease week over week - 2025-07-30 11:49:03
Y Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Y Intercept Hong Kong Ltd lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 17.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,720 shares of the biopharmaceutical company’s stock after selling 796 shares during the period. […] - 2025-07-25 06:12:53
Victory Capital Management Inc. Cuts Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Victory Capital Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,649 shares of the biopharmaceutical company’s stock after selling 2,148 shares during the period. Victory Capital […] - 2025-07-25 05:14:50
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twenty-two have assigned a buy recommendation to the […] - 2025-07-24 06:26:55
Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist Financial
Truist Financial initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $385.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on ALNY. Jefferies Financial […] - 2025-07-22 03:14:59
Nisa Investment Advisors LLC Cuts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Nisa Investment Advisors LLC cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 38.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,155 shares of the biopharmaceutical company’s stock after selling 5,162 shares during […] - 2025-07-14 05:54:56
Crossmark Global Holdings Inc. Takes Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Crossmark Global Holdings Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,018 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Other hedge funds have also modified their holdings of the […] - 2025-07-14 05:14:48
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the biopharmaceutical company’s stock after selling 113 shares during the […] - 2025-07-08 04:40:51
Mirae Asset Global Investments Co. Ltd. Sells 2,596 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 28.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,534 shares of the biopharmaceutical company’s stock after selling 2,596 shares during the […] - 2025-07-04 04:52:27
Wells Fargo & Company Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $333.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lifted by research analysts at Wells Fargo & Company from $287.00 to $333.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […] - 2025-07-02 03:05:01
Diversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Diversified Trust Co cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% in the first quarter, Holdings Channel reports. The institutional investor owned 1,482 shares of the biopharmaceutical company’s stock after selling 999 shares during the period. Diversified Trust Co’s holdings in Alnylam Pharmaceuticals were worth $400,000 as of […] - 2025-07-01 07:10:56
Sequoia Financial Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sequoia Financial Advisors LLC lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 3.0% in the first quarter, HoldingsChannel reports. The fund owned 3,395 shares of the biopharmaceutical company’s stock after acquiring an additional 99 shares during the period. Sequoia Financial Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $917,000 […] - 2025-07-01 05:22:50
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 12-Month High Following Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week high on Monday after Wells Fargo & Company raised their price target on the stock from $287.00 to $333.00. Wells Fargo & Company currently has an equal weight rating on the stock. Alnylam Pharmaceuticals traded as high as $327.05 and last […] - 2025-07-01 02:27:01
Kentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Kentucky Retirement Systems bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,794 shares of the biopharmaceutical company’s stock, valued at approximately $2,375,000. Several other institutional investors and […] - 2025-06-24 06:20:52

iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2025-11-12 (Wednesday)41,479ALNY holding increased by 288USD 18,779,202ALNY holding increased by 162930USD 18,779,202288USD 162,930 USD 452.74 USD 451.95
2025-11-11 (Tuesday)41,191USD 18,616,272ALNY holding increased by 422207USD 18,616,2720USD 422,207 USD 451.95 USD 441.7
2025-11-10 (Monday)41,191ALNY holding increased by 160USD 18,194,065ALNY holding increased by 29641USD 18,194,065160USD 29,641 USD 441.7 USD 442.7
2025-11-07 (Friday)41,031ALNY holding decreased by -16USD 18,164,424ALNY holding increased by 83631USD 18,164,424-16USD 83,631 USD 442.7 USD 440.49
2025-11-06 (Thursday)41,047ALNY holding decreased by -32USD 18,080,793ALNY holding increased by 229503USD 18,080,793-32USD 229,503 USD 440.49 USD 434.56
2025-11-05 (Wednesday)41,079ALNY holding increased by 104USD 17,851,290ALNY holding increased by 499607USD 17,851,290104USD 499,607 USD 434.56 USD 423.47
2025-11-04 (Tuesday)40,975ALNY holding increased by 128USD 17,351,683ALNY holding decreased by -378774USD 17,351,683128USD -378,774 USD 423.47 USD 434.07
2025-11-03 (Monday)40,847ALNY holding decreased by -64USD 17,730,457ALNY holding decreased by -926595USD 17,730,457-64USD -926,595 USD 434.07 USD 456.04
2025-10-31 (Friday)40,911USD 18,657,052ALNY holding increased by 265103USD 18,657,0520USD 265,103 USD 456.04 USD 449.56
2025-10-30 (Thursday)40,911ALNY holding increased by 400USD 18,391,949ALNY holding decreased by -1117743USD 18,391,949400USD -1,117,743 USD 449.56 USD 481.59
2025-10-29 (Wednesday)40,511ALNY holding increased by 400USD 19,509,692ALNY holding increased by 420466USD 19,509,692400USD 420,466 USD 481.59 USD 475.91
2025-10-28 (Tuesday)40,111ALNY holding increased by 40USD 19,089,226ALNY holding decreased by -87953USD 19,089,22640USD -87,953 USD 475.91 USD 478.58
2025-10-27 (Monday)40,071ALNY holding increased by 24USD 19,177,179ALNY holding increased by 618198USD 19,177,17924USD 618,198 USD 478.58 USD 463.43
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE000G2LIHG9

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12BUY288459.270447.130 448.344USD 129,123 304.66
2025-11-10BUY160449.680440.930 441.805USD 70,689 303.40
2025-11-07SELL-16443.587430.835 432.110USD -6,914 302.79 Loss of -2,069 on sale
2025-11-06SELL-32445.490429.000 430.649USD -13,781 302.18 Loss of -4,111 on sale
2025-11-05BUY104438.530417.000 419.153USD 43,592 301.58
2025-11-04BUY128431.500421.830 422.797USD 54,118 301.04
2025-11-03SELL-64457.260429.615 432.379USD -27,672 300.44 Loss of -8,444 on sale
2025-10-30BUY400471.980436.512 440.059USD 176,023 299.05
2025-10-29BUY400481.590482.730 482.616USD 193,046 298.22
2025-10-28BUY40475.910484.610 483.740USD 19,350 297.40
2025-10-27BUY24478.580485.360 484.682USD 11,632 296.57
2025-10-24BUY16463.430469.290 468.704USD 7,499 295.80
2025-10-21BUY24474.000490.050 488.445USD 11,723 293.38
2025-10-20BUY88491.220495.550 495.117USD 43,570 292.44
2025-10-16BUY80481.070488.390 487.658USD 39,013 290.64
2025-10-15BUY96470.270485.280 483.779USD 46,443 289.79
2025-10-03BUY32456.350465.010 464.144USD 14,853 288.11
2025-10-02BUY64460.990461.530 461.476USD 29,534 287.27
2025-10-01BUY96460.650467.420 466.743USD 44,807 286.43
2025-09-30BUY584456.000459.300 458.970USD 268,038 285.60
2025-09-29BUY152447.490451.630 451.216USD 68,585 284.80
2025-09-26BUY344446.400453.050 452.385USD 155,620 284.00
2025-09-25BUY24449.580459.000 458.058USD 10,993 283.18
2025-09-24BUY456458.370462.690 462.258USD 210,790 282.30
2025-09-18BUY96452.170456.940 456.463USD 43,820 281.45
2025-09-17BUY120451.730463.880 462.665USD 55,520 280.59
2025-09-16BUY192461.240467.280 466.676USD 89,602 279.67
2025-09-15BUY64461.140466.240 465.730USD 29,807 278.74
2025-09-11SELL-8468.580474.340 473.764USD -3,790 276.80 Loss of -1,576 on sale
2025-09-10BUY512469.310480.050 478.976USD 245,236 275.80
2025-09-09BUY32482.130484.210 484.002USD 15,488 274.73
2025-08-06BUY152428.140428.690 428.635USD 65,153 273.08
2025-07-31BUY40392.240402.430 401.411USD 16,056 271.67
2025-07-29BUY160330.550331.060 331.009USD 52,961 270.98
2025-07-28BUY32324.790331.430 330.766USD 10,585 270.69
2025-07-25BUY48328.810331.500 331.231USD 15,899 270.38
2025-07-24BUY24328.000332.190 331.771USD 7,963 270.06
2025-07-23BUY56325.640329.340 328.970USD 18,422 269.76
2025-07-22BUY32325.280326.300 326.198USD 10,438 269.45
2025-07-18BUY64320.530325.620 325.111USD 20,807 269.17
2025-07-17BUY48324.690329.870 329.352USD 15,809 268.86
2025-07-11BUY64314.940321.120 320.502USD 20,512 267.78
2025-07-10BUY72322.640324.820 324.602USD 23,371 267.46
2025-07-09BUY72320.870322.680 322.499USD 23,220 267.15
2025-07-07SELL-48324.130328.240 327.829USD -15,736 266.52 Loss of -2,943 on sale
2025-07-02SELL-200329.770330.000 329.977USD -65,995 265.37 Loss of -12,922 on sale
2025-06-27BUY24322.830323.200 323.163USD 7,756 264.66
2025-06-26BUY24318.250325.000 324.325USD 7,784 264.33
2025-06-24SELL-112325.000326.030 325.927USD -36,504 263.61 Loss of -6,980 on sale
2025-06-18BUY64312.320317.540 317.018USD 20,289 262.39
2025-06-17BUY24308.710309.060 309.025USD 7,417 262.10
2025-06-16SELL-32308.780309.630 309.545USD -9,905 261.80 Loss of -1,528 on sale
2025-06-13BUY72307.990308.020 308.017USD 22,177 261.51
2025-06-12SELL-40304.670307.480 307.199USD -12,288 261.23 Loss of -1,839 on sale
2025-06-11BUY88298.580303.850 303.323USD 26,692 260.98
2025-06-06BUY24300.830310.220 309.281USD 7,423 260.16
2025-06-05BUY112308.000308.530 308.477USD 34,549 259.84
2025-06-04BUY16305.310308.930 308.568USD 4,937 259.54
2025-06-03SELL-8303.770307.850 307.442USD -2,460 259.24 Loss of -386 on sale
2025-05-30SELL-976304.560306.000 305.856USD -298,515 258.61 Loss of -46,115 on sale
2025-05-29BUY24292.900293.220 293.188USD 7,037 258.37
2025-05-27BUY136290.100295.440 294.906USD 40,107 257.96
2025-05-23BUY120289.960291.220 291.094USD 34,931 257.50
2025-05-22BUY56289.000291.540 291.286USD 16,312 257.28
2025-05-19BUY48291.860296.800 296.306USD 14,223 256.52
2025-05-16BUY24285.310289.750 289.306USD 6,943 256.31
2025-05-15SELL-16283.400285.000 284.840USD -4,557 256.11 Loss of -460 on sale
2025-05-14BUY8267.550270.000 269.755USD 2,158 256.02
2025-05-13BUY16266.860268.070 267.949USD 4,287 255.94
2025-05-08BUY16258.350270.000 268.835USD 4,301 255.92
2025-05-07BUY24276.550277.850 277.720USD 6,665 255.76
2025-05-02BUY888259.390265.000 264.439USD 234,822 255.49
2025-04-30BUY280263.240263.680 263.636USD 73,818 255.43
2025-04-29BUY72257.190260.540 260.205USD 18,735 255.41
2025-04-28BUY56254.850256.570 256.398USD 14,358 255.42
2025-04-25BUY144251.560253.250 253.081USD 36,444 255.45
2025-04-24SELL-168242.610243.690 243.582USD -40,922 255.55 Profit of 2,011 on sale
2025-04-23BUY152241.970248.590 247.928USD 37,685 255.67
2025-04-22BUY64236.750238.630 238.442USD 15,260 255.82
2025-04-17BUY88234.560235.120 235.064USD 20,686 256.39
2025-04-15BUY80230.930242.150 241.028USD 19,282 256.83
2025-04-11BUY128237.770240.000 239.777USD 30,691 257.15
2025-04-09BUY48243.270245.560 245.331USD 11,776 257.55
2025-04-08BUY288224.320246.150 243.967USD 70,262 257.85
2025-04-07BUY96232.950241.830 240.942USD 23,130 258.08
2025-04-04SELL-128235.740259.160 256.818USD -32,873 258.29 Profit of 188 on sale
2025-04-02BUY1,088266.830267.290 267.244USD 290,761 258.21
2025-04-01BUY8255.760273.610 271.825USD 2,175 258.23
2025-03-31BUY56270.020271.850 271.667USD 15,213 258.12
2025-03-28BUY32268.460271.300 271.016USD 8,673 258.02
2025-03-27BUY16271.020276.570 276.015USD 4,416 257.90
2025-03-26BUY8269.210281.210 280.010USD 2,240 257.78
2025-03-25BUY88280.960292.620 291.454USD 25,648 257.55
2025-03-24BUY104290.700300.900 299.880USD 31,188 257.22
2025-03-21BUY96283.340289.440 288.830USD 27,728 256.96
2025-03-19BUY24253.440255.350 255.159USD 6,124 257.03
2025-03-18BUY288244.300263.300 261.400USD 75,283 257.16
2025-03-17BUY56253.110253.300 253.281USD 14,184 257.21
2025-03-14BUY416241.760244.040 243.812USD 101,426 257.37
2025-03-13BUY80241.750245.140 244.801USD 19,584 257.54
2025-03-12SELL-400242.430246.370 245.976USD -98,390 257.70 Profit of 4,691 on sale
2025-03-11SELL-296238.740243.450 242.979USD -71,922 257.91 Profit of 4,420 on sale
2025-03-10BUY88233.070244.330 243.204USD 21,402 258.19
2025-03-07BUY16244.520251.120 250.460USD 4,007 258.34
2025-03-05BUY120249.230249.820 249.761USD 29,971 258.44
2025-03-04BUY136242.930244.670 244.496USD 33,251 258.62
2025-03-03BUY256243.530250.000 249.353USD 63,834 258.80
2025-02-28BUY208246.750249.340 249.081USD 51,809 258.94
2025-02-27SELL-40237.100246.380 245.452USD -9,818 259.20 Profit of 550 on sale
2025-02-25BUY296245.200251.560 250.924USD 74,274 259.56
2025-02-21BUY32250.590253.700 253.389USD 8,108 259.80
2025-02-18SELL-72250.000260.000 259.000USD -18,648 260.16 Profit of 84 on sale
2025-02-14SELL-488256.450264.870 264.028USD -128,846 260.26 Loss of -1,837 on sale
2025-02-13BUY8264.890268.520 268.157USD 2,145 260.20
2025-02-12BUY80265.960268.200 267.976USD 21,438 260.12
2025-02-07SELL-8276.190278.030 277.846USD -2,223 259.57 Loss of -146 on sale
2025-02-06BUY152278.250279.240 279.141USD 42,429 259.30
2025-02-05BUY40276.310278.440 278.227USD 11,129 259.05
2025-02-04BUY48271.000277.980 277.282USD 13,310 258.87
2025-02-03BUY48274.550278.510 278.114USD 13,349 258.63
2025-01-31BUY88271.310279.340 278.537USD 24,511 258.44
2025-01-29SELL-8273.990279.700 279.129USD -2,233 257.89 Loss of -170 on sale
2025-01-28SELL-72279.190283.560 283.123USD -20,385 257.55 Loss of -1,841 on sale
2025-01-27SELL-128276.730287.220 286.171USD -36,630 257.23 Loss of -3,704 on sale
2025-01-24BUY96278.760279.670 279.579USD 26,840 256.87
2025-01-23BUY16275.540277.220 277.052USD 4,433 256.56
2025-01-22BUY136266.540269.140 268.880USD 36,568 256.39
2025-01-21BUY96264.990265.020 265.017USD 25,442 256.23
2025-01-16BUY160249.160256.930 256.153USD 40,984 256.74
2025-01-14BUY64240.510259.600 257.691USD 16,492 257.16
2025-01-10BUY192237.980240.170 239.951USD 46,071 257.52
2024-12-30BUY24236.010236.950 236.856USD 5,685 259.78
2024-12-27BUY32237.970243.610 243.046USD 7,777 260.27
2024-12-23BUY240242.260244.640 244.402USD 58,656 261.56
2024-12-20BUY64245.440247.210 247.033USD 15,810 261.96
2024-12-19BUY8238.870242.870 242.470USD 1,940 262.55
2024-12-18BUY64237.920247.050 246.137USD 15,753 263.20
2024-12-17BUY16246.580249.580 249.280USD 3,988 263.65
2024-12-16BUY80243.990247.930 247.536USD 19,803 264.20
2024-12-13BUY64245.440249.510 249.103USD 15,943 264.73
2024-12-10BUY400253.910257.990 257.582USD 103,033 265.38
2024-12-09BUY48255.890258.120 257.897USD 12,379 265.68
2024-12-06SELL-120256.260257.810 257.655USD -30,919 265.98 Profit of 999 on sale
2024-12-05SELL-8251.810255.290 254.942USD -2,040 266.45 Profit of 92 on sale
2024-12-03BUY40251.840253.210 253.073USD 10,123 267.40
2024-11-27SELL-48253.740256.020 255.792USD -12,278 269.73 Profit of 669 on sale
2024-11-26BUY168253.350253.740 253.701USD 42,622 270.44
2024-11-25BUY1,929250.980255.460 255.012USD 491,918 271.33
2024-11-22SELL-14244.890248.900 248.499USD -3,479 272.59 Profit of 337 on sale
2024-11-21SELL-40246.800250.710 250.319USD -10,013 273.88 Profit of 942 on sale
2024-11-20SELL-16248.790249.100 249.069USD -3,985 275.20 Profit of 418 on sale
2024-11-19BUY8234.270235.940 235.773USD 1,886 277.47
2024-11-18BUY72232.270242.490 241.468USD 17,386 280.13
2024-11-11BUY24279.820286.580 285.904USD 6,862 280.89
2024-11-07BUY20272.220275.070 274.785USD 5,496 281.83
2024-11-06BUY192273.010278.210 277.690USD 53,316 282.56
2024-11-05BUY40265.290268.890 268.530USD 10,741 284.13
2024-11-04BUY14269.950272.920 272.623USD 3,817 285.55
2024-11-01BUY21273.910274.030 274.018USD 5,754 286.84
2024-10-30SELL-48281.490287.870 287.232USD -13,787 290.50 Profit of 157 on sale
2024-10-29SELL-144284.690287.020 286.787USD -41,297 291.47 Profit of 674 on sale
2024-10-28SELL-56286.910290.940 290.537USD -16,270 292.38 Profit of 103 on sale
2024-10-21SELL-8292.010295.390 295.052USD -2,360 0.00 Loss of -2,360 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19216,7273,259396,24354.7%
2025-09-18172,875397386,43244.7%
2025-09-17246,547167472,29252.2%
2025-09-1688,84660226,33639.3%
2025-09-15148,25813,572435,68934.0%
2025-09-12134,122300244,96854.8%
2025-09-11219,8687,820411,70253.4%
2025-09-10543,3267,595916,89859.3%
2025-09-09705,54033,7311,550,89945.5%
2025-09-08175,158440388,71545.1%
2025-09-05127,116335311,25240.8%
2025-09-04110,9302,555236,56846.9%
2025-09-03182,3868,982562,92132.4%
2025-09-02132,77014,416358,47637.0%
2025-08-2993,2162,181276,59433.7%
2025-08-2860,1821,254226,86526.5%
2025-08-27277,6671,084440,57763.0%
2025-08-26243,404919447,42154.4%
2025-08-25156,55115,662374,27641.8%
2025-08-22228,5961,309408,15256.0%
2025-08-21123,9962,862248,30049.9%
2025-08-20149,63813,723316,98347.2%
2025-08-19144,3201,143308,39946.8%
2025-08-18371,31834,264525,78670.6%
2025-08-15104,01813,245265,62039.2%
2025-08-14133,2724,443505,52826.4%
2025-08-13183,2711,3901,017,62318.0%
2025-08-12173,0454,046693,01825.0%
2025-08-11239,1997,600451,24853.0%
2025-08-08168,7553,199466,74436.2%
2025-08-07308,8104,452527,39958.6%
2025-08-06202,15112,590548,34936.9%
2025-08-05256,29513,237826,28331.0%
2025-08-04411,11436,303729,94956.3%
2025-08-01350,06060,108764,94345.8%
2025-07-31829,1916,0231,541,01553.8%
2025-07-30533,88514,703942,78856.6%
2025-07-29164,26855384,53742.7%
2025-07-28150,24069571,96526.3%
2025-07-2590,782429298,80130.4%
2025-07-24132,00111,546286,15546.1%
2025-07-23184,14963312,34059.0%
2025-07-22134,7617,553524,61225.7%
2025-07-21113,303101243,11946.6%
2025-07-1884,1179196,31742.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.